ArticleCureus2025
Atrial Wall Perforation After Atrial Septal Defect Device Closure: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transcatheter device closure is currently the first modality of choice in the management of secundum atrial septal defects (ASDs). We report a seven-year-old child with secundum ASD who underwent transcatheter ASD device closure using the Amplatzer septal occluder (ASO) (AGA Medical Corporation, Golden Valley, Minnesota, United States). Two weeks after the procedure, the patient presented with life-threatening acute pericardial effusion as a result of atrial roof erosion. Diagnosis was confirmed by echocardiography and cardiac CT scan. Surgical removal of the device and repair of the tear in the atrium together with ASD closure were done. Although rare, cardiac erosion is a significant and life-threatening complication after transcatheter ASD device closure that should not be underestimated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.